Shankar Musunuri is the founder of Ocugen. Ocugen has raised $30M in total funding. Latest round: IPO. Backed by Avenue Venture Opportunities Fund, L.P..
Shankar Musunuri is the Chairman, Chief Executive Officer, and Co-founder of Ocugen, a biotechnology company based in Malvern, PA. Ocugen focuses on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines for various diseases including retinal, infectious, and orthopedic conditions. The company recently secured $30 million in debt funding from Avenue Venture Opportunities Fund, L.P. for general corporate purposes and to advance clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library